A model for estimating costs and benefits of new vaccine technologies from the perspective of both buyers and sellers.

ABSTRACT: Although vaccination is widely considered one of the most cost-effective health interventions available, global coverage rates for many vaccines remain lower than necessary for disease elimination and eradication. New vaccine technologies can play an important role in addressing barriers to vaccination and increasing coverage rates. To identify and prioritize vaccine technology investments, decision makers must be able to compare the overall costs and benefits of each investment option. While these data points may exist, they are often confined to silos. Decision makers would benefit from a model that synthesizes this broad range of data and provides clear and actionable information. To facilitate vaccine investment, purchasing and deployment decisions, we developed a systematic and transp

SUBMITTER: Krautmann M 

PROVIDER: S-EPMC10075404 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature